MLchartDataset catalogue

pegylated interferon alfa

Term · Oncology and biomedicine · MLC-T-ONC-015924

A covalent conjugate of recombinant interferon alpha and polyethylene glycol (PEG), used as an antiviral and antineoplastic agent. The biological activity of this agent is derived from its interferon alpha protein moiety. Interferons alfa bind to specific cell-surface receptors, leading to the transcription and translation of genes whose protein products mediate antiviral, antiproliferative, anticancer, and immune-modulating effects. The PEG moiety lowers the clearance of interferon alpha, thereby extending the duration of its therapeutic effects, but may also reduce interferon-mediated stimulation of an immune response.

Table 1. Record
IdentifierMLC-T-ONC-015924
FieldOncology and biomedicine
AbbreviationPEG-IFN-a
SynonymsPEG-interferon alfa
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-015924",
  "term": "pegylated interferon alfa",
  "field": "Oncology and biomedicine",
  "definition": "A covalent conjugate of recombinant interferon alpha and polyethylene glycol (PEG), used as an antiviral and antineoplastic agent. The biological activity of this agent is derived from its interferon alpha protein moiety. Interferons alfa bind to specific cell-surface receptors, leading to the transcription and translation of genes whose protein products mediate antiviral, antiproliferative, anticancer, and immune-modulating effects. The PEG moiety lowers the clearance of interferon alpha, thereby extending the duration of its therapeutic effects, but may also reduce interferon-mediated stimulation of an immune response.",
  "abbreviation": "PEG-IFN-a",
  "synonyms": [
    "PEG-interferon alfa"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/pegylated-interferon-alfa/"
}

Record 12,869 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.